Association of prothrombin gene mutation (G20210A) with recurrent pregnancy loss
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20253064Keywords:
Association, Prothrombin gene mutation (G20210A), Recurrent pregnancy lossAbstract
Background: Recurrent pregnancy loss (RPL) is a significant reproductive health concern, often with multifactorial etiologies. Among the possible causes, thrombophilic gene mutations, such as the Prothrombin G20210A mutation, has the most potential role. This study aimed to investigate the association between Prothrombin G20210A gene mutation and RPL in a selected group of Bangladeshi women.
Methods: This case-control study was carried out in the outpatient Department of Fetomaternal Medicine, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh, from December 2020 to May 2021. Total 35 women with history of recurrent pregnancy losses were selected as cases. The control group consisted of 35 women with at least one successful pregnancy and no history of recurrent pregnancy loss.
Results: Out of 35 cases two patients have Prothrombin gene mutation, one in 1st trimester and another in 2nd trimester. One was primary RPL and another one was secondary RPL. Normal homozygous (GG) were 94.3% and mutant heterozygous (GA) were 5.7%, mutant homozygous (AA) were 0.0% in case group. In control group there were no mutation of prothrombin gene (G20210A). The difference was statistically not significant (p=0.421) between two groups. Fisher exact test was done. This test was done to see the results were statistically significant or not. It is usually employed when sample sizes are small but it is valid for all sample sizes.
Conclusions: This study found no statistically significant association between the Prothrombin G20210A gene mutation and recurrent pregnancy loss. Although 5.7% of cases had heterozygous mutations, none were observed in controls.
Metrics
References
Bender Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S. ESHRE Guideline Group on RPL, ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2018;2(2):4. DOI: https://doi.org/10.1093/hropen/hoy004
Abu-Asab NS, Ayesh SK, Ateeq RO, Nassar SM, El-Sharif WA. Association of inherited thrombophilia with recurrent pregnancy loss in Palestinian women. Obstet Gynecol Int. 2011;2011:1–6. DOI: https://doi.org/10.1155/2011/689684
Abdelsalam T, Karkour T, Elbordiny M, Shalaby D, Abouzeid ZS. Thrombophilia gene mutations in relation to recurrent miscarriage. Int J Reprod Contracept Obstet Gynecol. 2018;7(3):796–800. DOI: https://doi.org/10.18203/2320-1770.ijrcog20180857
Settin A, Alkasem RA, Ali E, ElBaz R, Mashahey AM. Factor V Leiden and prothrombin gene mutations in Egyptian cases with unexplained recurrent pregnancy loss. Hematology. 2011;16(1):59–63. DOI: https://doi.org/10.1179/102453311X12902908411959
Badawy A, AlSel BA, Fawzy MS. Factor V Leiden G1691A and Prothrombin G20210A mutations are associated with repeated spontaneous miscarriage in Northern area of Saudi Arabia. Genet Mol Res. 2017;16(4):653. DOI: https://doi.org/10.4238/gmr16039810
Prat M, Morales-Indiano C, Jimenez C, Mas V, Besses C, Checa MA, et al. “20209C-T” a Variant Mutation of Prothrombin Gene Mutation in a Patient with Recurrent Pregnancy Loss. Ann Clin Lab Sci. 2014;44(3):334–6.
Abu-Heija A. Thrombophilia and Recurrent Pregnancy Loss: Is heparin still the drug of choice. Sultan Qaboos Univ Med J. 2014;14(1):26. DOI: https://doi.org/10.18295/2075-0528.1543
Bigdeli R, Younesi MR, Panahnejad E, Asgary V, Heidarzadeh S, Mazaheri H, et al. Association between thrombophilia gene polymorphisms and recurrent pregnancy loss risk in the Iranian population. Syst Biol Reprod Med. 2018;64(4):274–82. DOI: https://doi.org/10.1080/19396368.2018.1456576
Gao H, Tao FB. Prothrombin G20210A mutation is associated with recurrent pregnancy loss: a systematic review and meta-analysis update. Thromb Res. 2015;135(2):339–46. DOI: https://doi.org/10.1016/j.thromres.2014.12.001
Nassour-Mokhtari I, Loukidi B, Moussaoui A, Bettioui R, Benhabib R, Merzouk H, et al. Inherited thrombophilia and recurrent pregnancy loss: a single-center case-control study in North-Western Algeria. Egypt J Med Hum Genet. 2020;21(1):1–7. DOI: https://doi.org/10.1186/s43042-020-00077-1
Nikolaeva MG, Momot AP, Zainulina MS, Yasafova NN, Taranenko LA. Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity. Thromb J. 2021;19(1):1–8. DOI: https://doi.org/10.1186/s12959-021-00289-4
Lund M, Nielsen HS, Hviid TV, Steffensen R, Nyboe Andersen A, Christiansen OB. Hereditary thrombophilia and recurrent pregnancy loss: a retrospective cohort study of pregnancy outcome and obstetric complications. Hum Reprod. 2010;25(12):2978–84. DOI: https://doi.org/10.1093/humrep/deq280
Yenicesu GI, Cetin M, Ozdemir O, Cetin A, Ozen F, Yenicesu C, et al. A prospective case–control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss. Am J Reprod Immunol. 2010;63(2):126–36. DOI: https://doi.org/10.1111/j.1600-0897.2009.00770.x
Altintas A, Pasa S, Akdeniz N, Cil T. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Ann Hematol. 2007;86:727–31. DOI: https://doi.org/10.1007/s00277-007-0327-1
Sehirali S, Inal MM, Yildirim Y, Balim Z, Kosova B, Karamizrak T, et al. Prothrombin G20210A mutation in cases with recurrent miscarriage: a study of the Mediterranean population. Arch Gynecol Obstet. 2005;273(3):170–3. DOI: https://doi.org/10.1007/s00404-005-0061-7
Downloads
Published
How to Cite
Issue
Section
